Dr. Mary B. Daly on When to Screen Patients With a Family History of Cancer

Additional exploration may help fully realize the impact of combining immunologic approaches with PARP inhibition, says one expert.

Nicole Gay, APRN-C, shares how nurse navigators can talk to their patients about lung cancer screening.

Perioperative atezolizumab did not improve outcomes in patients with triple-negative breast cancer.

Ryan Tamargo, NP, AONCP, discusses the launch of an online inflammatory breast cancer scoring system tool.

“This benefit in local recurrence translates into a later difference in distant recurrence and breast cancer [mortality], but it’s only apparent with long follow-up,” according to the study author.

Neoadjuvant camrelizumab paired with chemotherapy could represent a new option in early or locally advanced triple-negative breast cancer.